Cargando…

Ribavarin Should Be Tested in Clinical Trials in Combination With Other Antiviral Agents for Severe Acute Respiratory Syndrome

Detalles Bibliográficos
Autores principales:	Chu, Chung-Ming, Chan, Kin-Sang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American College of Chest Physicians. Published by Elsevier Inc. 2005
Materias:	Communications to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130147/ https://www.ncbi.nlm.nih.gov/pubmed/16354884 http://dx.doi.org/10.1016/S0012-3692(15)49656-4

Ejemplares similares

Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C
por: Saab, Sammy, et al.
Publicado: (2017)

Novel Antiviral Agents for Respiratory Viral Infection in Immunocompromised Adults
por: Hawkinson, Dana, et al.
Publicado: (2013)

Antiviral Agents Against Respiratory Viruses
por: Ison, Michael G., et al.
Publicado: (2017)

Antiviral agents against respiratory viruses
por: Tremblay, Cecile L.
Publicado: (2001)

Cardiac Toxicity Associated with HCV Direct Antiviral Agents
por: Ucciferri, Claudio, et al.
Publicado: (2018)

Antiviral Drugs for Influenza and Other Respiratory Virus Infections
por: Aoki, Fred Y.
Publicado: (2015)

Takotsubo Cardiomyopathy related to Pheochromocytoma or Other Etiology Should Be Considered as Similar
por: Champion, Sébastien
Publicado: (2015)

When should we be able to divert the cost of tuberculosis to other diseases?
por: Mukhida, Sahjid S., et al.
Publicado: (2023)

Clinical severe acute respiratory syndrome coronavirus 2 isolation and antiviral testing
por: Mathez, Gregory, et al.
Publicado: (2021)

Antiviral combinations for severe influenza
por: Dunning, Jake, et al.
Publicado: (2014)

Should ondansetron be used as a routine prophylaxis agent for postoperative nausea and vomiting?
por: Kendall, Mark C., et al.
Publicado: (2018)

No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
por: Molina, J.M., et al.
Publicado: (2020)

Skin testing with bendamustine: what concentration should be used?
por: Malinauskiene, Laura, et al.
Publicado: (2020)

Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain
por: Siu, Kam-Leung, et al.
Publicado: (2014)

Hyperglycemia and adverse pregnancy outcome (HAPO) study: Should it show the other side of the coin?
por: Gupta, Yashdeep, et al.
Publicado: (2014)

Epicardial Adipose Tissue Should Be Evaluated with Other Inflammatory Markers in Patients with Subclinical Hypothyroidism
por: Balta, Sevket, et al.
Publicado: (2013)

Anti-anonymity should not be taken more seriously than other positions on gamete donation
por: Pennings, Guido
Publicado: (2023)

What respiratory physicians should know about narcolepsy and other hypersomnias
por: Klaus, Stephen, et al.
Publicado: (2022)

Who should receive oral antiviral therapy for severe acute respiratory syndrome coronavirus 2 infection in the omicron era? Choose wisely
por: Weiss, Guenter
Publicado: (2023)

Bacterial and fungal colonization of the respiratory tract in COVID-19 patients should not be neglected
por: Intra, Jari, et al.
Publicado: (2020)

Diagnostic performance of antigen testing for severe acute respiratory syndrome coronavirus 2
por: Marchán-López, Álvaro, et al.
Publicado: (2021)

A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses
por: Fung, Sin-Yee, et al.
Publicado: (2020)

Severe acute respiratory illness pandemics: coronavirus disease 2019 and other viral etiologies in the 21st century
por: Jain, Parul, et al.
Publicado: (2020)

Reply to: Anti-anonymity should not be taken more seriously than other positions on gamete donation
por: Groll, Daniel
Publicado: (2023)

Before blaming SARS-CoV-2 for GBS, other causes should be ruled out
por: Finsterer, Josef, et al.
Publicado: (2023)

Severe Acute Respiratory Syndrome: Relapse? Hospital Infection?
por: Tsang, Owen Tak-Yin, et al.
Publicado: (2003)

Antiviral Agents
por: Reines, Eric D., et al.
Publicado: (1988)

Antiviral Agents
por: Paintsil, E., et al.
Publicado: (2019)

Antiviral Agents
por: Paintsil, E., et al.
Publicado: (2009)

Clinical applications of antiviral agents for chemophrophylaxis and therapy of respiratory viral infections
por: Hayden, Frederick G.
Publicado: (1985)

Trendelenburg in Acute Respiratory Distress Syndrome: Should We Do More than Proning?
por: Datta, Priyankar K, et al.
Publicado: (2022)

Brain hypoxia caused by respiratory obstruction which should not be forgotten in COVID-19 disease
por: URAKOV, Aleksandr, et al.
Publicado: (2022)

Development of antiviral therapy for severe acute respiratory syndrome
por: Cinatl, Jindrich, et al.
Publicado: (2005)

Nanoformulation-Based Antiviral Combination Therapy for Treatment of COVID-19
por: Keshmiri Neghab, Hoda, et al.
Publicado: (2020)

Testing the Asymptomatic Pre-Surgical Population for Severe Acute Respiratory Syndrome Coronavirus 2
por: Bobenchik, April M., et al.
Publicado: (2021)

Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
por: Gordon, Calvin J., et al.
Publicado: (2020)

Should depressive patients undergo a regular diabetes screening test?
por: Ghosh, Subhasish, et al.
Publicado: (2013)

Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses
por: McKimm-Breschkin, Jennifer L., et al.
Publicado: (2016)

Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered
por: Deltenre, Pierre, et al.
Publicado: (2021)

Response to: Before blaming SARS-CoV-2 vaccinations for rhabdomyolysis, other potential triggers should be considered
por: Jung, Jiwon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dlfuma2epkikgmvn4il9b2bu4s